Articles
Recent Articles
Article
February 1, 2023
2022 Year in Review: Key Trademark Cases in Canada
Article
January 26, 2023
2022 Year in Review: Electrical & Computer Technology
Article
January 17, 2023
2022 Year in Review: Canadian Copyright
Article
January 16, 2023
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative...
Article
January 12, 2023
Significant Changes to the European Patent System Are Coming in 2023 – Here is What Canadian Applicants...
Article
January 10, 2023
Canadian Grant Agency Raises Clinical Trial Reporting Requirements
Article
December 23, 2022
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use I...
Article
December 15, 2022
Preparing the Expert Report in a Patent Case – A Collaborative Exercise to be Approached with C...
Article
December 12, 2022
Getting Transparent About Transparency: Canadian Registration and Reporting of Clinical Trials
Article
December 9, 2022
Crocs’ Design Takes a Bite Out of the Competition
Article
December 6, 2022
Skating to Where the Puck Is Going to Be - How the IRAP ‘IP Assist’ Program Can Help With Startup...
Article
December 2, 2022
The Role of IP Management in Product Development
Article Archive
-
IP, Digital Identity, and Branding in the Metaverse and Web3 – Part I: Digital Identity and the Creator Economy
November 25, 2022 -
70 Is the New 50: Term of Copyright Protection in Canada to Become "Life Plus 70" on December 30, 2022
November 24, 2022 -
Order Vacated; Order Restored—BOMBAY FRANKIE Injunction Appeal Allowed
November 24, 2022 -
USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims
November 16, 2022 -
PMPRB Regulations Saga Coming to an End? New Draft Guidelines Issued
November 10, 2022 -
IP Metaverse Series - Part IV: Pitching Metaverse Advertising in Canada – Opportunities and Legal Considerations
November 2, 2022 -
United States Court of Appeals for the Federal Circuit Holds That an Artificial Intelligence System Cannot Be an Inventor on a Patent Application
October 21, 2022 -
Form II: Anticipation and Obviousness of Crystal Form Patents in the Federal Court of Canada
September 26, 2022 -
Class certification for privacy breaches, not so easy to come by
September 23, 2022 -
Is this Drug Safe and Effective Enough? Canadian Regulators Wade into Alzheimer’s Drug Controversy
August 26, 2022